Latest News

Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superiority over conventional

A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeting shows the

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section

Ovesco Endoscopy AG partnered in an innovative training network focusing on “Wireless in-body environment communications”

In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in 92.3 %

The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucosal dissection and full-thickness resection as

EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in

The medical technology company located in Tuebingen will officially inaugurate its new building in the

Ovesco is proud to announce that LiftUp® has received market approval in Europe. It is

The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer agent

When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed comparable results (93

To err is human – to help is, too! Due to a missed exhibition stand

In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCap was successful

For Ovesco Endoscopy AG, product innovation is among their core competences. Within the framework of

Gastric EFTR in 29 patients with gastric SET led to en-bloc resection in 89.7 %,

Digestive Disease Week – DDW 2019: – National and international multicenter studies confirm that the

On the occasion of the 1st Family Day in the new building, the ovesco Endoscopy

German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft für Koloproktologie – DGK) together

93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with

In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of

Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved

Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the

After moving to its new company headquarters in the Technology Park Tuebingen at the beginning

Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %

ovesco Endoscopy AG moved to its new headquarters on April 29, 2019 and will thus

Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resection

The AWC was used in 8 patients with GI lesions 17-45 mm (average 35.9 mm)

Ovesco is proud to announce that both the OTSC® System and the remOVE System including

6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all

EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a

96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower

Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success

Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurrence/relapse of previous endoscopic

Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA

OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of

In a multicentric cohort of 100 consecutive patients with mean age 72 y, 51 %

Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the familyNET Award

OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical significance

Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional working channel (AWC®)

All 19 patients were treated successfully with the OTSC System. In 74 % of cases,

Multicenter study shows high technical success rate and significant improvement of dysphagia symptoms. B Walter

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section

100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first

87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al.,

66.6 % of patients with leaking from the “J” of the tip of an ileo-anal

Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric study

Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg, Germany, presented a

A systematic literature review evaluating efficacy and safety of the OTSC System in the management

Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa,

Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented data from three

As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protection and

Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the

Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, USA, reported their

Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, presented

Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, France, presented a

OTSC has long been described in the scientific literature as a highly effective device for

Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, Switzerland, reported about their

Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distributor of Medical Device

Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with the learned

Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University Hospital Ulm, received the

Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce

A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institute of Pathology,

The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesellschaft für

El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – Northwell

PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectiology, University Hospital

J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, performed a

Ovesco is proud to announce the launch of the BougieCap. A new method for the

Ovesco announces that the remOVE System has been cleared by the US Food and Drug

Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD

One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Rudolf-Eberle-Prize – has

Ovesco is proud to announce that OTSC has received market approval in Peru. The product

Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UEG

Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong,

Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section

Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has an extensive experience

In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headquarters for management,

Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, Freiburg,

Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German companies. The

Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized controlled study shows significant

Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger Medizintechnikunternehmen errichtet

Ovesco publishes an updated OTSC® update containing further relevant publications on research conducted with the

Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD

Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong,

Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD

Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from

R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo Regina

Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium

Dr. Malay Sharma from North India received the audiovisual award for the use of the

Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and Infectiology, Ludwigsburg Hospital, Germany, received

The internet platform Endoscopy Campus is providing the latest information about endoscopy. Together with DGVS

HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and Department of General and Visceral